Portuguese biotechnology company Immunethep is receiving $2 million from CARB-X to develop a conjugate peptide-based vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback